Trazodone and mianserin in general practice

Area of Science:

• Psychiatry
• Clinical Pharmacology

Background:

• Depression and anxiety are common conditions in general practice.
• Pharmacological interventions are a cornerstone of treatment.
• Comparing the efficacy and tolerability of different antidepressant medications is crucial for optimizing patient care.

Purpose of the Study:

• To compare the efficacy and tolerability of trazodone and mianserin in treating depression in general practice patients.
• To assess the impact of these medications on depression and anxiety symptoms.
• To evaluate patient-reported side effects and withdrawal rates.

Main Methods:

• A double-blind, noncrossover study involving 125 general practice patients with depression (minimum Hamilton Depression Rating Scale score of 14).
• Patients were randomized to receive either trazodone (100-200 mg nocte) or mianserin (60-120 mg nocte) for 6 weeks.
• Efficacy was assessed using the Hamilton Depression Rating Scale (HDRS) and anxiety symptoms using the Zung Self-Rating Anxiety Scale.

Main Results:

• Both trazodone and mianserin significantly reduced depression and anxiety symptoms, with comparable efficacy (mean HDRS decrease from ~21 to ~6 for both).
• Withdrawal rates due to side effects were significantly higher in the mianserin group (22/31) compared to the trazodone group (5/12) (p < 0.001).
• Daytime drowsiness was a frequent reason for mianserin withdrawal.

Conclusions:

• Trazodone and mianserin demonstrate similar effectiveness in treating depression and anxiety.
• Trazodone is better tolerated than mianserin, with significantly fewer withdrawals due to side effects.
• Trazodone may be a more acceptable treatment option for general practice patients with depression, considering its improved side effect profile.